LABU ETF — Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU)

Updated October 16, 2026.

LABU is an ETF that tracks the S&P Biotechnology Select Industry Index. its distribution rate is 0.05%, its trailing-12-month yield is 0.46%, its expense ratio is 0.96%. Dividend Vision Distribution Safety Score™ is 9/100 (High risk). Total return is -93.5% over the past 11.4 years, 427.6 points behind SPY at 334.1%.

Direxion Daily S&P Biotech Bull 3X Shares is an ETF that seeks to deliver three times the daily performance of the S&P Biotechnology Select Industry Index through leveraged exposure via swap agreements and related financial instruments. The fund has a modest current distribution rate, distributes quarterly with a recent special distribution, and carries an expense ratio of 0.96%. This leveraged equity fund appeals to active traders and investors seeking amplified short-term exposure to the biotechnology sector, though the daily reset mechanism means results over longer periods may differ significantly from three times the index's performance.

LABU performance versus SPY

Price and return data through 2026-10-16.

Total return is -93.5% over the past 11.4 years, 427.6 points behind SPY at 334.1%. Over the past year its total return — price change plus distributions reinvested — is 72.3%. Its deepest 1-year drawdown was 41.8%.

LABU key facts

Distribution Safety Score™

9 · High risk

Safety-Adjusted Yield

0.00%

Issuer

Direxion

Asset type

ETF

Asset class

Equity

Inception date

05/28/2015

Expense ratio

0.96%

Distribution rate

0.05%

Distribution frequency

Quarterly

Trailing yield

0.46%

Last close

$198.86 (as of 2026-10-16)

AUM

$620,152,459

Average volume

475928.0

Dividend

$0.91

Ex-dividend date

12/23/2025

Payment date

12/31/2025

Beta

3.16

How Dividend Vision calculates yield and returns

Distribution rate (0.05%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (0.46%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Direxion or company page; Index: S&P Biotechnology Select Industry Index; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

LABU risks and drawbacks

LABU's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 41.8%.

Who may consider LABU — and who may not

It is a weaker fit for investors who need monthly cash flow (LABU pays quarterly); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on LABU

• All tickers starting with L

Tagged: Leverage, Healthcare.

Frequently asked questions

More securities from Direxion.